often have been excluded from subsequent surgical treatment because of increased ICP. 1, 48 Many of these patients today can be treated using endovascular techniques, thus avoiding surgery in the swollen brain. Whether endovascular treatment affects outcome in these poor-grade patients is only beginning to be determined. 13, 22, 30, 32 Furthermore, the causes of elevated ICP in poor-grade patients have not been precisely defined, nor has the relationship between increased ICP and hospital course in good-grade patients been studied in detail.
Thus, in this study we evaluated the factors associated with increased ICP and the relationship between ICP and outcome after SAH. We analyzed data from 433 patients who had undergone craniotomy following aneurysm rupture as well as placement of ICP monitoring devices. We observed the following: 1) increased ICP often can be predicted by admission clinical or radiographic findings; 2) despite the reliability of admission findings as predictors, ICP is often elevated even in good-grade patients; and 3) elevated ICP, particularly if unresponsive to treatment, is significantly associated with poor outcome (and this association is observed across clinical grades). Nevertheless, results of multivariate analysis indicate that increased ICP may not always be an independent predictor of outcome.
Clinical Material and Methods

Patient Population
Consecutive patients retrospectively identified from an observational database of patients treated for aneurysmal SAH at a Level I trauma center were included in this analysis. Inclusion criteria consisted of the following: 1) known SAH from a radiographically documented aneurysm, 2) admission clinical Hunt and Hess Grades I to V, 21 and 3) placement of an ICP monitor during the patient's hospital stay. Data in the observational database had been abstracted from patient hospital records including clinical notes, intensive care unit flow sheets, surgery reports, anesthesia records, head CT scans and angiograms, and 6-month follow-up information collected during a clinic visit or a telephone interview. 28, 29 
Management Protocol
Patients received care according to a standard policy based on published recommendations. 28, 29, 31, 38 During both prehospital and hospital courses, patients underwent aggressive resuscitation procedures including intubation, ventilation, fluid resuscitation, and mannitol administration when appropriate. All patients received phenytoin, dexamethasone, and nimodipine. Patients were evaluated using noncontrast and infusion CT scanning or CT angiography. 42 In patients with aneurysmal ICH and brainstem compression, the hematoma was removed and the aneurysm occluded within 8 hours of ictus; no angiography was performed. 33 All other patients underwent angiography and were treated in the neurosurgery intensive care unit before aneurysm occlusion. Patients were surgically treated as soon as possible and within 24 hours of admission. During surgery, the brain was relaxed using osmotic diuresis (mannitol 1-2 mg/kg and furosemide 20-40 mg) and CSF drainage. Patients underwent craniotomy and standard microvascular techniques to obliterate the aneurysm. A decompressive hemicraniectomy was performed if cerebral swelling was evident during closure. Patients were not routinely treated with intraoperative hyperventilation, and intraoperative hypotension was avoided. Postsurgical care included CT scanning, angiography, invasive hemodynamic monitoring, and aggressive treatment of intracranial hypertension and vasospasm. Postoperative ICP monitoring devices (Camino; Integra Neurosciences, Plainsboro, NJ) were used in all patients for a minimum of 72 hours unless care was withdrawn or the patient died first. The monitoring device was removed only when ICP had been normal for 24 hours without treatment. In addition to ongoing monitoring patients with hydrocephalus received ventricular drains. Increased ICP (Ͼ 20 mm Hg) was treated with the correction of systemic abnormalities such as hypoxia or increased temperature, ventilation, sedation, mannitol administration, and ventricular drainage. When elevated ICP remained unresponsive to these measures, barbiturate agents were administered or patients underwent decompressive hemicraniectomy.
Measuring Patient Outcome
Patient outcome was assessed immediately after surgery based on the GCS 53 and 6 months after surgery by using the GOS. 23 The GOS has five levels: good recovery; moderate disability; severe disability; vegetative state; and death. Patients with a GOS level of good or moderate are able to live independently and are described as having a favorable outcome. Patients with a GOS level of severe, vegetative, or dead are considered to have an unfavorable outcome.
Statistical Analysis
The relationship between ICP and clinical, radiographic, and outcome variables was assessed using two methods. First, the patient population was separated into three groups based on the mean maximal ICP (Ͻ 20, 20-50, and Ͼ 50 mm Hg). This value was obtained by recording the maximal ICP at each hour; these maximums were averaged for each day and the patient was classified according to the daily maximum. Intracranial pressure values of 20 and 50 mm Hg were chosen because an ICP greater than 20 mm Hg is a well-known factor associated with poor outcome and is used as a threshold for treatment in patients with head injury, whereas 50 mm Hg represents a Lundberg A or plateau wave. 6, 35, 37, 41, 47, 49 The relevant variables and patient characteristics were then compared among the three groups to determine whether there were statistically significant differences. In addition, the same variables were compared with a continuous range of ICPs to determine and confirm their significance. To do this, ICP was continuously recorded and all values obtained in a single hour were averaged. The maximal mean hourly value obtained during the hospital course was used in a continuous analysis.
All data are expressed as the mean Ϯ standard deviation of the mean. When data were not distributed normally, the median value was used to describe the data. Bivariate and univariate analyses were used to generate probability value, standard deviations, and means by using the KruskalWallis nonparametric analysis of variance test or the chisquare approximate. Linear relationships were examined using Spearman correlations. Statistical significance was defined as a probability value less than 0.05. Statistically significant variables obtained in univariate and bivariate analyses were then tested using logistic regression techniques to determine independence. All statistical analyses were performed using commercially available software (version 8.2; SAS Institute, Inc., Cary, NC) and Instat (version 2.03; GraphPad Software, San Diego, CA).
Results
Patient Characteristics
During a 10-year period, 433 patients underwent craniotomy and placement of an ICP monitoring device for a ruptured aneurysm. All patients received postoperative ICP monitoring, and 146 patients (33.7%) received both preand postoperative ICP monitoring. Immediate surgery was performed in 29 moribund patients for aneurysmal ICH. In patients with both pre-and postoperative ICP monitoring devices, there was an approximate 1:1 relationship in ICP values (p Ͻ 0.0001). The mean age of patients was 51.2 Ϯ 14.4 years, and 278 (64.2%) were female and 155 (35.8%) were male. Two hundred seventy nine patients (64.4%) had a good clinical grade (Hunt and Hess Grades I-III) and 154 (35.6%) had a poor clinical grade (Hunt and Hess Grades IV and V) on admission.
Intracranial Pressure Values
During their hospital stay, 234 patients (54%) had elevated ICP (Ն 20 mm Hg). The mean maximal ICP in the entire patient population was 24.9 Ϯ 17.3 mm Hg. Intracranial pressure values were similar when obtained from an intraparenchymal or a ventricular monitor when both were placed; all analyses were based on values obtained from the intraparenchymal ICP monitor. The patient population was separated into three groups based on the mean maximal ICP during the hospital course: normal, less than 20 mm Hg ICP; moderately elevated, 20 to 50 mm Hg ICP; and severely elevated, greater than 50 mm Hg ICP. In this study, 199 patients (46%) had normal, 207 (47.8%) had moderately elevated, and 27 (6.2%) had severely elevated ICP. Intracranial pressure was increased in patients in all clinical grades, including 136 (48.7%) of 279 patients with a good clinical grade (Hunt and Hess Grades I-III) and 98 (63.6%) of 154 patients with a poor clinical grade (Hunt and Hess Grades IV and V; Fig. 1 ). Elevated ICP was treated using mannitol (72.2%), barbiturates (1.7%), hematoma evacuation, or decompressive hemicraniectomy (5.6%), and/or ventricular drains (20.1%). When ICP was between 20 and 50 mm Hg, 96% of patients experienced a decrease in ICP in response to treatment; when ICP was greater than 50 mm Hg, only 44% of patients had a response to therapy. Three complications-a nonfunctional monitor requiring replacement, a CSF leak around the monitoring device, and a retained fragment requiring surgical removal-were associated with ICP monitor use.
Preoperative Variables
There was a significant relationship between both admission intubation (p Ͻ 0.0001) and increased ICP and preoperative rebleeding (p Ͻ 0.0048) and increased ICP (Tables  1 and 2 ). Forty-one patients experienced rebleeding; their mean maximal ICP was 36.6 Ϯ 26.6 mm Hg. In contrast, ICP among those who did not rebleed was 23.7 Ϯ 15.5 mm Hg (Table 1) . Furthermore, ICP was associated with worse Hunt and Hess grade (p Ͻ 0.0001) and GCS motor score (p Ͻ 0.0001; Fig. 1 ). Patient age, sex, premorbid medical disorders, and admission findings (such as blood pressure, serum sodium, serum glucose, hematocrit, and arterial blood gas levels, or cardiac function) were not associated with ICP (data not shown).
Several admission radiological variables from head CT scanning and angiography studies were analyzed to determine their relationship to the different patient groups (Tables 2 and 3). Radiographic evidence of herniation, SDH, low-density changes on CT studies, aneurysm size, or vasospasm were similar in the three ICP groups. In contrast, worse SAH grade on CT scans (according to the modified Fisher scale, 30 ,31 p Ͻ 0.0001), ventricular effacement on CT scans (p = 0.024), IVH (p = 0.014), and ICH (p = 0.024) occurred more frequently in patients with increased ICP. There also was a significant association between increased ICP and overall severity of ventricular effacement (p = 0.016) and severity of IVH (p = 0.003).
Perioperative Variables
A variety of perioperative variables were considered. 26, 27 Intraoperative cerebral swelling (p = 0.0017) occurred more frequently in patients with raised ICP and was observed in 13.1% of patients with normal ICP, 20.0% with moderately elevated ICP, and 41.7% with severely elevated ICP. The incidence of intraoperative aneurysm rupture or hypotension was similar in all three patient groups. Tables 2 and 4 feature the association between several postoperative variables and ICP. There was an association between the number of blood units transfused and ICP (p = 0.0052) but no relationship between hematocrit and ICP. The former was true primarily in patients with moderately elevated ICP-because many patients with severely elevated ICP died early in their hospital course. Secondary cerebral insults, such as hypoxia or hyperglycemia, were not associated with ICP. In contrast, an episode of hypotension was associated with severely elevated ICP based on group (p = 0.036) but not continuous analysis. There was a tendency toward angiographically demonstrated vasospasm, but only in group analysis (p = 0.02) was vasospasm more frequent among patients with increased ICP. Symptomatic vasospasm was not associated with increased ICP. There were more days spent on ventilators in patients with increased ICP (p Ͻ 0.0001), ranging from 3.6 Ϯ 6.2 days in patients with normal ICP to 5.6 Ϯ 7.6 days in those with moderately elevated ICP and 5.7 Ϯ 4.9 days in patients with severely elevated ICP. This relationship was not observed when ICP was examined as a continuous variable.
Postoperative Variables
Patient Outcome
Patients with intracranial hypertension had a lower immediate postoperative motor component on the GCS (p Ͻ 0.0001) and a worse GOS score (p Ͻ 0.0001) 6 months postoperatively ( Table 5 ). The majority of patients with normal ICP (71.9%) and moderately elevated ICP (67.5%) had favorable outcomes at 6 months postoperatively (Fig. 2) . In contrast, only 33.3% of patients with severely elevated ICP had favorable outcomes. Similarly, death occurred more frequently in patients with intracranial hypertension. In 21 patients whose raised ICP did not respond to mannitol therapy, all experienced a poor outcome and 95.2% died. Among 145 patients whose elevated ICP responded to treatment, 66.9% had a favorable outcome and 20.7% were dead 6 months postoperatively (p Ͻ 0.0001; Fig. 3 ). The relationship between increased ICP and patient outcome was true when stratified for each clinical grade (Fig. 4) 
Discussion
In this study we analyzed the medical data for 433 patients with SAH, each of whom had undergone placement of ICP monitoring devices and surgery to occlude a ruptured aneurysm. Our findings are consistent with those from In previous studies the presence of intracranial hypertension has been associated with poor outcome. We report two new and interesting findings: 1) increased ICP occurs in nearly half of the good-grade patients (Hunt and Hess Grades I-III); and 2) failure of increased ICP to respond to treatment is always associated with poor outcome, although many patients whose elevated ICP can be controlled can have a satisfactory outcome. Results of multivariate analysis, however, indicate that ICP alone may not always be an independent variable in outcome.
Incidence of Intracranial Hypertension
Our findings demonstrate that 54% of patients admitted for SAH have intracranial hypertension during their hospital stay, including 6% whose ICP is greater than 50 mm Hg. Patients with increased ICP generally had a worse clinical grade-both a worse GCS motor score and a worse Hunt and Hess grade-on admission. Nonetheless, there were a significant number of patients (48.7%) admitted with a good clinical grade (Hunt and Hess Grades I-III) who also had moderately or severely elevated ICP. Consistent with this finding, in a study of 36 patients with SAH, including four good-grade patients (Hunt and Hess Grades I-III), Tomei, et al., 54 observed that good-grade patients, like poorgrade patients, had periods of intracranial hypertension. Together, these data indicate that intracranial hypertension, although more common in poor-grade patients, can occur regardless of the patient's clinical grade following aneurysmal SAH.
Variables Associated With Intracranial Hypertension
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Intracranial pressure and aneurysmal subarachnoid hemorrhage 413 3 . Bar graph illustrating patient outcome 6 months postoperatively and response to mannitol therapy. The graph is separated into groups of patients with increased ICP who responded (145 patients) or did not respond (21 patients) to mannitol. The total number of patients experiencing favorable or unfavorable outcome in each group is demonstrated by the entire bar height. Specific outcomes are illustrated by a specific shade: white (favorable); gray (severe disability and vegetative state); and black (death). Outcome was significantly associated with no response to treatment (p Ͻ 0.0001); specifically, poor outcome was associated with elevated ICP that is unresponsive to mannitol therapy.
Surprisingly, factors such as SDH, radiographic evidence of herniation, or low-density changes indicating edema or infarct on admission CT scans were not significantly associated with increased ICP. This finding may be explained in part because some of these patients had undergone early surgery, often together with decompressive hemicraniectomy, before placement of an ICP monitor. Similarly, Smith, et al., 50 observed that there was improved ICP control in select poor-grade patients who had undergone prophylactic decompressive hemicraniectomy. Nevertheless, analysis of our results indicates that all poor-grade patients with SAH should receive ICP monitoring during treatment. Intracranial pressure may be monitored in poor-grade patients by using an external ventricular drain; however, several authors have observed that ventricular drainage increases the risk of aneurysm rebleeding, a variable in our series that was associated with increased ICP. 15, 45, 46, 56 Ventricular drainage should be performed carefully to avoid changes in transmural pressure that may precipitate rebleeding; therefore, we generally prefer intraparenchymal ICP monitoring devices because their use is safe and not associated with aneurysm bleeding, unless there is severe hydrocephalus or IVH. An external ventricular drain can subsequently be placed in patients who show an elevated ICP on intraparenchymal monitoring and in patients who require CSF drainage for control of ICP.
In this study, approximately half of the good-grade patients experienced increased ICP during their hospital course. The obvious question arises: should all good-grade patients receive ICP monitoring? We believe that such widespread use is unnecessary, but we do recommend that physicians consider the placement of ICP monitors in goodgrade patients who have ICH, IVH, or a thick SAH on admission CT scanning, or who clinically deteriorate subsequently. The presence of a thick SAH may be particularly important because it often is associated with hydrocephalus or later development of vasospasm. In patients at higher risk for vasospasm there may be a benefit in the placement of an ICP monitor: data from transcranial Doppler studies have demonstrated that high ICP can worsen vasospasm, whereas a reduction in elevated ICP can prevent the development of vasospasm. 10 Similarly, Gambardella, et al., 12 observed that osmotic diuretics used to treat elevated ICP in patients with Hunt and Hess Grade I or II could also reverse clinical signs of delayed ischemia. In patients being considered for angioplasty, placement of an ICP monitor might also be considered given that papaverine can increase ICP. 8 Finally, if a good-grade patient experiences rebleeding or if significant cerebral swelling occurs during surgery, then placement of an ICP monitor should be strongly considered.
Some variables such as preoperative intubation or number of days on ventilator may represent epiphenomenathey are generally linked to the patient's condition or represent a first line of treatment for increased ICP. There was little difference, however, in the number of days spent on a ventilator in patients with moderately or severely elevated ICP, in part because those with severely increased ICP often died early in their hospital stay. Similarly, an association between moderately, but not severely, elevated ICP and blood transfusion was observed. This relationship also may represent an epiphenomena, but it is noteworthy that data from several recent clinical trials indicate that blood transfusions for anemia in patients in critical care units may exacerbate outcome or contribute to organ ischemia. 18, 19, 36, 57 A very weak, if viable, association was demonstrated between angiographic or symptomatic vasospasm and increased ICP. There are several potential explanations for this nearly absent association. First, patients with severely elevated ICP often died early in their hospital stays before vasospasm could develop. In addition, a few of these patients, because they were critically ill, did not undergo follow-up angiography studies. Second, an association between hydrocephalus and vasospasm has been well described. 3, 7 Many of the patients with hydrocephalus would have had a ventricular drain in place, controlling ICP. In animal studies, vasoconstriction often is independent of ICP; 2 in some clinical studies, however, an association between increased ICP and angiographic arterial spasm can be absent. 17 Intracranial pressure monitors can be useful in patients with symptomatic vasospasm because some may demonstrate clinical improvement on control of their ICP. In addition, patients receiving hypervolemia hypertension therapy can develop cerebral edema.
Intracranial Hypertension and Patient Outcome
The most important finding in this study was that intracranial hypertension is associated with worse patient outcome. Nonetheless, a significant number of patients with elevated ICP, including a third with severely elevated ICP, still had favorable outcomes and a third of patients with normal ICP had unfavorable outcomes (28.1%). Consequently, with the use of multivariate analysis we found that ICP was not an independent predictor of outcome. These results demonstrate that although ICP is an important factor in patient outcome following SAH, elevated ICP may not be an absolute determinant of patient outcome. This finding is not surprising given the complex pathophysiology of SAH that includes reduced cerebral blood flow, impaired autoregulation, decreased CO 2 reactivity, systemic abnormalities such as decreased intravascular volume, or biochemical abnormalities such as excitotoxicity, each of which may contribute to poor outcome.
In many poor-grade patients, intracranial hypertension has often been used as an exclusion criterion for subsequent surgical treatment. 1, 48 We believe that response to treatment is associated with outcome and should be used, in lieu of the elevation of ICP alone, as the primary criterion by which to select patients for therapy or continued care. In our population, 21 patients had severely elevated ICP that did not respond to mannitol therapy; 20 died and one survived but was severely disabled. In such patients it may be appropriate to withhold some forms of treatment.
Conclusions
A potential limitation of this study is our failure to consider patients whose aneurysms were occluded by the use of endovascular techniques. Some patients with severely elevated or nonresponsive ICP may be better treated with endovascular techniques. Nonetheless, in recent studies in poor-grade patients treated with endovascular techniques compared with those treated with conservative management or surgery, researchers observed similar outcomes. 13, 22 Consequently, we believe the results in this series may be generalized to most patients treated with endovascular techniques because it is primarily patient condition and the ways in which the consequences of SAH are managed that determine the increases, if any, in ICP as well as patient outcome.
